[HTML][HTML] Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: a systematic review
H Iino, M Hashiguchi, S Hori - PloS one, 2022 - journals.plos.org
Background Decision-making in healthcare policy involves assessing both costs and
benefits. In determining the cost-effectiveness (CE) threshold, willingness to pay (WTP) per …
benefits. In determining the cost-effectiveness (CE) threshold, willingness to pay (WTP) per …
Understanding the global measurement of willingness to pay in health
JA McDougall, WE Furnback, B Wang… - Journal of market access …, 2020 - mdpi.com
Objective: To understand the different methodologies used to elicit willingness to pay for
health and the value of a statistical life year through surveys. Methodology: A systematic …
health and the value of a statistical life year through surveys. Methodology: A systematic …
Estimating a cost‐effectiveness threshold for the Spanish NHS
L Vallejo‐Torres, B García‐Lorenzo… - Health …, 2018 - Wiley Online Library
The cost of generating a quality‐adjusted life year (QALY) within a National Health Service
provides an approximation of the average opportunity cost of funding decisions. This …
provides an approximation of the average opportunity cost of funding decisions. This …
[HTML][HTML] On the estimation of the cost-effectiveness threshold: why, what, how?
Background Many health care systems claim to incorporate the cost-effectiveness criterion in
their investment decisions. Information on the system's willingness to pay per effectiveness …
their investment decisions. Information on the system's willingness to pay per effectiveness …
[HTML][HTML] Factors and situations influencing the value of patient preference studies along the medical product lifecycle: a literature review
E van Overbeeke, C Whichello, R Janssens… - Drug discovery today, 2019 - Elsevier
Highlights•Use of patient preferences in decision making is limited but gaining
attention.•Some situations and decisions are more sensitive to patient preferences than …
attention.•Some situations and decisions are more sensitive to patient preferences than …
Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression
CRC Kouakou, TG Poder - The European Journal of Health Economics, 2022 - Springer
The use of a threshold for cost-utility studies is of major importance to health authorities for
making the best allocation decisions for limited resources. Regarding the increasing number …
making the best allocation decisions for limited resources. Regarding the increasing number …
[HTML][HTML] A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
K Nimdet, N Chaiyakunapruk, K Vichansavakul… - PloS one, 2015 - journals.plos.org
Background A number of studies have been conducted to estimate willingness to pay (WTP)
per quality-adjusted life years (QALY) in patients or general population for various diseases …
per quality-adjusted life years (QALY) in patients or general population for various diseases …
[HTML][HTML] ¿ Qué es una intervención sanitaria eficiente en España en 2020?
JA Sacristán, J Oliva, C Campillo-Artero… - Gaceta …, 2020 - SciELO Public Health
Hace más de 15 años que en Gaceta Sanitaria se publicó el artículo titulado «¿ Qué es una
tecnología sanitaria eficiente en España?». El creciente interés por fijar el precio de las …
tecnología sanitaria eficiente en España?». El creciente interés por fijar el precio de las …
[HTML][HTML] A systematic review of demand-side methods of estimating the societal monetary value of health gain
M Thavorncharoensap, U Chaikledkaew, S Youngkong… - Value in Health, 2021 - Elsevier
Objectives Although many reviews of the literature on cost-effectiveness thresholds (CETs)
exist, the availability of new studies and the absence of a fully comprehensive analysis …
exist, the availability of new studies and the absence of a fully comprehensive analysis …
[HTML][HTML] Opportunities and challenges for the inclusion of patient preferences in the medical product life cycle: a systematic review
R Janssens, I Huys, E van Overbeeke… - BMC medical informatics …, 2019 - Springer
Background The inclusion of patient preferences (PP) in the medical product life cycle is a
topic of growing interest to stakeholders such as academics, Health Technology Assessment …
topic of growing interest to stakeholders such as academics, Health Technology Assessment …